Total Payments
$8,477
2024 Payments
$1,454
Companies
39
Transactions
480
Medicare Patients
6,687
Medicare Billing
$501,079
Payment Breakdown by Category
Food & Beverage$7,663 (90.4%)
Education$813.69 (9.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,663 | 435 | 90.4% |
| Education | $813.69 | 45 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,913 | 117 | $0 (2024) |
| LEO Pharma Inc. | $809.29 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $800.21 | 44 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $640.78 | 26 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $638.64 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $569.12 | 31 | $0 (2024) |
| GENZYME CORPORATION | $347.33 | 18 | $0 (2024) |
| PFIZER INC. | $329.25 | 19 | $0 (2024) |
| Aqua Pharmaceuticals | $278.82 | 14 | $0 (2017) |
| TARO PHARMACEUTICALS USA, INC. | $259.98 | 39 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,454 | 77 | ABBVIE INC. ($506.79) |
| 2023 | $1,495 | 72 | LEO Pharma Inc. ($284.57) |
| 2022 | $1,394 | 74 | LEO Pharma Inc. ($288.79) |
| 2021 | $777.02 | 54 | AbbVie Inc. ($203.87) |
| 2020 | $553.70 | 24 | Janssen Biotech, Inc. ($130.30) |
| 2019 | $627.09 | 35 | AbbVie, Inc. ($151.83) |
| 2018 | $749.43 | 69 | Taro Pharmaceuticals USA, Inc. ($212.58) |
| 2017 | $1,426 | 75 | AbbVie, Inc. ($308.29) |
All Payment Transactions
480 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Immunology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.21 | General |
| Category: Immunology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $38.48 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $47.99 | General |
| Category: Immunology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.77 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.01 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.25 | General |
| Category: Immunology | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Immunology | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,740 | 4,115 | $227,117 | $147,299 |
| 2022 | 15 | 1,712 | 3,828 | $196,137 | $130,070 |
| 2021 | 13 | 1,518 | 3,436 | $161,579 | $107,977 |
| 2020 | 11 | 1,717 | 3,743 | $180,165 | $115,733 |
Total Patients
6,687
Total Services
15,122
Medicare Billing
$501,079
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 591 | 1,211 | $110,259 | $71,918 | 65.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 473 | 859 | $59,518 | $38,917 | 65.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 105 | 105 | $11,907 | $7,571 | 63.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 355 | 1,572 | $11,917 | $7,310 | 61.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 71 | $5,130 | $3,649 | 71.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 34 | 39 | $4,483 | $2,965 | 66.1% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 17 | 17 | $4,190 | $2,769 | 66.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 14 | $4,178 | $2,738 | 65.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 61 | $3,404 | $2,451 | 72.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $2,783 | $2,182 | 78.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $2,143 | $1,410 | 65.8% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 14 | 14 | $2,832 | $1,164 | 41.1% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $1,502 | $996.93 | 66.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 68 | $1,696 | $706.56 | 41.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 19 | $1,084 | $537.83 | 49.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 23 | $92.00 | $14.35 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 553 | 1,032 | $94,949 | $64,656 | 68.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 459 | 770 | $52,772 | $33,324 | 63.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 103 | 103 | $11,688 | $7,520 | 64.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 390 | 1,608 | $11,822 | $7,125 | 60.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 20 | 84 | $5,992 | $4,459 | 74.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 52 | 57 | $6,465 | $4,434 | 68.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 12 | 14 | $2,783 | $2,195 | 78.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2022 | 14 | 16 | $2,896 | $2,049 | 70.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 11 | $1,571 | $1,176 | 74.9% |
About Dr. Michael Gross, M.D
Dr. Michael Gross, M.D is a Dermatology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932105285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gross, M.D has received a total of $8,477 in payments from pharmaceutical and medical device companies, with $1,454 received in 2024. These payments were reported across 480 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,663).
As a Medicare-enrolled provider, Gross has provided services to 6,687 Medicare beneficiaries, totaling 15,122 services with total Medicare billing of $501,079. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Virginia Beach, VA
- Active Since 06/22/2005
- Last Updated 05/23/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932105285
Products in Payments
- DUPIXENT (Biological) $794.21
- ADBRY (Biological) $666.34
- SKYRIZI (Biological) $595.57
- TREMFYA (Drug) $581.11
- Sotyktu (Drug) $569.12
- RINVOQ (Biological) $498.61
- Humira (Biological) $470.39
- EUCRISA (Drug) $313.98
- ILUMYA (Biological) $305.29
- Odomzo (Drug) $212.11
- Cordran (Drug) $189.46
- HUMIRA (Biological) $185.82
- Tremfya (Drug) $143.64
- Winlevi (Drug) $139.00
- TALTZ (Drug) $128.12
- DUPIXENT (Drug) $126.59
- COSENTYX (Drug) $120.54
- Erivedge (Biological) $119.69
- COSENTYX (Biological) $119.13
- Xolair (Biological) $97.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Virginia Beach
Dr. Diego Dasilva, Md, MD
Dermatology — Payments: $425,606
Dermatology $425,606
Dr. Tara Buehler-Bota, M.d, M.D
Dermatology — Payments: $18,613
Dermatology $18,613
Padman Menon, M.d, M.D
Dermatology — Payments: $14,633
Dermatology $14,633
Mrs. Kimberly Soderberg, Md, MD
Dermatology — Payments: $10,921
Dermatology $10,921
Beatrix Edmonds, Md, MD
Dermatology — Payments: $10,689
Dermatology $10,689
Dr. George Harr, M.d, M.D
Dermatology — Payments: $6,612
Dermatology $6,612